Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel
Uitgebreid zoeken

Koffiekamer Terug naar discussie overzicht

welke pennystock kan je het beste kopen?

1.073 Posts
Pagina: «« 1 ... 49 50 51 52 53 54 »» | Laatste | Omlaag ↓
  5. Brugge4ever 10 april 2024 11:19

    • Brugge4ever

      Lid sinds: 18 jan 2023

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 55

      Gegeven: 78

    •    Aantal posts: 519

    Gisteren bij Intrasense een deel rond 41/42 cent verkocht om een groot deel van de mooie stijging om te zetten in effectieve winst. Nu bij de winstnemingen weer bijgekocht met als laatste order een pluk binnen op €0,34. Laatzijde blijft heel dun.
  7. Wereldhave 11 april 2024 14:06

    • Wereldhave

      Lid sinds: 05 okt 2021

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 17

      Gegeven: 12

    •    Aantal posts: 98

    MKB Nedsense heeft een belang in Tib-Tec AG.

    TIB-TEC AG recently organized an event for its investors on November 29th, 2023 in Amsterdam, hosted by its CEO, Kai Niedermeyer, alongside the Board of Directors. The event served as a platform to provide comprehensive updates on recent achievements, shedding light on significant milestones and outlining the company’s strategic trajectory moving forward.

    Here are the key highlights from the event:

    Technology Development Milestones: The event provided an insight on the recent achievements in technology development. TIB-TEC proudly announced the successful results stemming from its latest round of tests, underscoring the company’s commitment to innovation and advancement in its field.
    Legal and Patent Applications: In addition to technological progress, TIB-TEC also highlighted significant accomplishments in the legal realm, particularly emphasizing progress in patent applications. This underscores the company’s dedication to protecting its intellectual property and fostering a robust foundation for future growth.
    Industry Focus: An integral component of the event was the discussion surrounding the industries TIB-TEC is targeting. The company provided insights into the specific sectors it aims to penetrate, highlighting strategic opportunities for growth and innovation.
    Outlook on R&D and Business Development: Attendees were presented a comprehensive outlook on the company’s future endeavors, with a particular focus on Research and Development (R&D) initiatives and Business Development strategies. TIB-TEC delineated the steps ahead, explaining its vision for continued expansion and success.
    With an impressive turnout of over 80 attendees, the event was a great success. It fostered fruitful interactions and immediate follow-up discussions with investors, who demonstrated their commitment to supporting TIB-TEC’s future growth plans. The enthusiastic engagement of investors underscores the confidence in the company’s vision and potential.

    In conclusion, the TIB-TEC Investor Event was an important moment in the company’s journey, showcasing notable achievements, outlining strategic priorities, and fostering valuable investor relationships. As TIB-TEC continues to chart a course towards innovation and growth, the event stands as a testament to the company’s firm commitment to excellence and forward-thinking leadership.

    Zie:
    tib-tec.com
  9. StudentBelegger 12 april 2024 10:46

    • StudentBelegger

      Lid sinds: 12 apr 2024

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 1

      Gegeven: 0

    •    Aantal posts: 11

    Biosenic op dit moment al 24hr suspended by market operators met een nieuwsbericht op EuroNext over een 'global restructuring plan covering the years 2024-2030'. Voorspelling wat hier de uitkomst van gaat zijn?
  10. forum rang 10 DeZwarteRidder 12 april 2024 10:48

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 20915

      Gegeven: 9495

    •    Aantal posts: 96.920

    quote:

    StudentBelegger schreef op 12 april 2024 10:46:

    Biosenic op dit moment al 24hr suspended by market operators met een nieuwsbericht op EuroNext over een 'global restructuring plan covering the years 2024-2030'. Voorspelling wat hier de uitkomst van gaat zijn?
    Veel nieuwe aandelen en verwatering.
  11. forum rang 4 Diede 12 april 2024 12:31

    • Diede

      Lid sinds: 10 mei 2020

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 561

      Gegeven: 86

    •    Aantal posts: 1.021

    quote:

    StudentBelegger schreef op 12 april 2024 10:46:

    Biosenic op dit moment al 24hr suspended by market operators met een nieuwsbericht op EuroNext over een 'global restructuring plan covering the years 2024-2030'. Voorspelling wat hier de uitkomst van gaat zijn?
    Je kan je geld terugvorderen bij Brugge.
  14. StudentBelegger 15 april 2024 09:42

    • StudentBelegger

      Lid sinds: 12 apr 2024

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 1

      Gegeven: 0

    •    Aantal posts: 11

    quote:

    Diede schreef op 12 april 2024 12:31:

    [...]
    Je kan je geld terugvorderen bij Brugge.
    Vaker stuivers gegraaid bij dit aandeel met kleine bedragen 6-10% pakken op een dag en een paar keer verlies genomen als het orderboek geen stijging meer voorziet.
    Koers houd zich nog sterk, gezien het orderboek zal de koers nog wel even tussen 0,2 en 0,26 kunnen bungelen. Genoeg ruimte voor daghandel!
  15. Brugge4ever 15 april 2024 12:19

    • Brugge4ever

      Lid sinds: 18 jan 2023

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 55

      Gegeven: 78

    •    Aantal posts: 519

    Intrasense lichtrood maar laatzijde blijft mager dus ik verwacht verder herstel sinds de dip naar €0,27. Vanochtend bij opening Belysse gekocht op €0,755. Recent waren er nog meerdere insider aankopen tussen 80 en 96 cent.
  16. Brugge4ever 15 april 2024 12:21

    • Brugge4ever

      Lid sinds: 18 jan 2023

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 55

      Gegeven: 78

    •    Aantal posts: 519

    quote:

    Diede schreef op 12 april 2024 12:31:

    [...]
    Je kan je geld terugvorderen bij Brugge.
    Misschien moeten de beleggers die met Lavide de boot in zijn gegaan dat ook maar bij jou doen :-))
  17. forum rang 10 DeZwarteRidder 15 april 2024 13:41

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 03 mei 2024

    • Aanbevelingen

      Ontvangen: 20915

      Gegeven: 9495

    •    Aantal posts: 96.920

    BioSenic S.A. • Rue Granbonpré 11 - Building H (box 24) • 1435 Mont-St-Guibert • Belgium (Europe) • Phone: +32 (0)493 09 73 66
    www.biosenic.com
    PRESS RELEASE - PRIVILEGED INFORMATION 11/04/2024
    1
    BioSenic and its restructuring practitioner (Me Yves Brulard) submit a
    global restructuring plan covering the years 2024-2030 to the Enterprise
    Court of Nivelles
    A final circular of the creditors on the basis of XX 83/23 of the Economic Law Code (ELC) will take place before the
    Court grants authorisation, in accordance with article XX 83/26 of the ELC, to submit the plan to the vote of each
    class of creditors and to homologation. The creditors will be aware of the plan, which by law contains information
    that could be privileged.
    Mont-Saint-Guibert, Belgium, 11 April 2024, 14:00 CET – BioSenic (Euronext Brussels and Paris: BIOS), the
    clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy announces that it
    has finalised a draft plan with the request referred to in Article XX 83/26 ELC with the Enterprise Court of Nivelles. Creditors
    will be notified to register their claims in RegSol. They will be able to consult this plan in order to then vote on the proposals
    made.
    The proposed plan provides for differentiated treatment of creditors by class:
    • The plan does not affect the recent financing provided through the convertible bond facilities.
    • Some obligators have been offered to replace their outstanding loans granted to BioSenic for a total principal
    amount of EUR 7.5 million with new convertible bonds to be issued by BioSenic. The convertible bonds would be
    unsecured and would have a maturity date of 31 December 2030, which could be further extended by BioSenic
    for up to 24 months depending on its cash balance. An interest rate of 5% per year, payable annually, with an
    additional non-compounding interest of 3% per year that would be added to the principal amount upon conversion
    or repayment of a convertible bond. Under this proposal, which has already been agreed in principle, 200,000
    outstanding warrants would be cancelled. The plan, if approved, would remove the conditions precedent
    previously agreed.
    • The plan provides that an outstanding EUR 8 million principal loan would be replaced by new convertible bonds
    to be issued by BioSenic. The convertible bonds would be unsecured and would have a maturity date of 31
    December 2030, which could be further extended by BioSenic for up to 24 months depending on its cash balance.
    An interest rate of 5% per year, payable annually, with an additional non-compounding interest of 3% per year
    that will be added to the principal amount upon conversion or repayment of a convertible bond. If the plan is
    approved, 800,000 outstanding warrants would also be cancelled.
    • With regard to the ordinary creditors, the plan provides for a payment by BioSenic of 5% of the claim on the last
    day of the 5th year of the plan.
    • With respect to the lessor, the plan provides for the extraordinary part 100% immediately and the balance in
    ordinary.
    • Regarding the strategic creditors, the plan provides for 90% over 5 years depending on cash inflows and no later
    than the last day of the 5th year of the plan.
    • For the accessories employee, the plan provides for 99% immediately.
    • The plan provides, for the very useful creditors, for 50% within 2 years.
    • Regarding the InterCos debts, the plan provides for 5% immediately.
    • Finally, with regard to the shareholders, the plan provides for the allocation of subscription rights, the terms of
    which will be determined at a later date by BioSenic.
    The plan includes a participation clause at the reorganisation value, due on the last day of the 5th year following the
    homologation of the plan on the basis of the average share price over the preceding 90 days. This participation amount –
    to be deducted from the company's own financing capacity for projects in the 5th year, with trials to be started or even
    maintained on new indications – will be due on the last day of the 5th year following the homologation of the plan, and will
    be assessed on the basis of the average share price over the preceding 90 days: the average share price will have to reach
    the level observed for the shares of BioSenic in 2017 while a Phase III was ongoing (JTA004). At that time, the share price
    stood at EUR 10. If this level is reached, the participation of every creditor will be increased by 10% of the debt written off.
1.073 Posts
Pagina: «« 1 ... 49 50 51 52 53 54 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.286
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.453
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.942
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.476
Aedifica 2 832
Aegon 3.257 320.091
AFC Ajax 537 7.018
Affimed NV 2 5.762
ageas 5.843 109.778
Agfa-Gevaert 13 1.862
Ahold 3.536 73.983
Air France - KLM 1.024 34.348
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.774
Alfen 12 16.534
Allfunds Group 3 1.217
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 337
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.765
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.359
AMG 965 125.845
AMS 3 73
Amsterdam Commodities 303 6.522
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.161
Apollo Alternative Assets 1 17
Apple 5 315
Arcadis 251 8.623
Arcelor Mittal 2.024 318.662
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.113
Aroundtown SA 1 176
Arrowhead Research 5 9.283
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.700
ASML 1.762 77.051
ASR Nederland 18 4.122
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.667
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 06 mei

    1. China inkoopmanagersindex diensten april
    2. PostNL Q1-cijfers
    3. Siemens Healthineers Q1-cijfers
    4. TKH Q1-cijfers
    5. Dui inkoopmanagersindex diensten april (def)
    6. EU inkoopmanagersindex diensten april (def)
    7. VK inkoopmanagersindex diensten april (def)
    8. EU producentenprijzen maart
    9. Tyson Foods Q1-cijfers

  2. 07 mei

    1. Japan inkoopmanagersindex diensten april
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht
Naar de hele agenda